| 000 | 01014 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515004457.0 | ||
| 264 | 0 | _c20060228 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a1083-7159 | ||
| 024 | 7 |
_a10.1634/theoncologist.10-90001-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBody, Jean-Jacques | |
| 245 | 0 | 0 |
_aBisphosphonates in metastatic bone disease: renal safety matters. _h[electronic resource] |
| 260 |
_bThe oncologist _c2005 |
||
| 300 |
_a1-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadverse effects |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 773 | 0 |
_tThe oncologist _gvol. 10 Suppl 1 _gp. 1-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.10-90001-1 _zAvailable from publisher's website |
| 999 |
_c15890505 _d15890505 |
||